Metraipolis › archive › dc_368c1e4589ef

Three-monthly gonadotropin-releasing hormone agonist for ovarian function suppression in premenopausal breast cancer: a systematic review and meta-analysis — Europe PMC PMID:42283761

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42283761
DOI
10.1007/s10549-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-10-31T13:16:51.505Z
SHA-256 of the archived text
d76cc002baf7eecc0fedb2652332f79e0e6ffdfadd01f1df8cd11254a2d22465
Stable URL of this page
https://metraipolis.com/documento/dc_368c1e4589ef

How to cite

Three-monthly gonadotropin-releasing hormone agonist for ovarian function suppression in premenopausal breast cancer: a systematic review and meta-analysis — Europe PMC PMID:42283761 — Europe PMC (en), https://europepmc.org/article/MED/42283761 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_368c1e4589ef (Metraipolis archive dc_368c1e4589ef, sha256 d76cc002baf7eecc0fedb2652332f79e0e6ffdfadd01f1df8cd11254a2d22465)
BibTeX
@misc{dc368c1e4589ef,
  title = {Three-monthly gonadotropin-releasing hormone agonist for ovarian function suppression in premenopausal breast cancer: a systematic review and meta-analysis — Europe PMC PMID:42283761},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42283761},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_368c1e4589ef; sha256 d76cc002baf7eecc0fedb2652332f79e0e6ffdfadd01f1df8cd11254a2d22465},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42283761. Agents can read the archived copy with the MCP tool read_document.